期刊文献+

肝硬化性心肌病研究 被引量:6

Progresses of Cirrhotic Cardiomyopathy
暂未订购
导出
摘要 肝硬化性心肌病是肝硬化的并发症之一,主要表现为心脏舒张功能减低、心排血量增加、全身血管阻力降低。一旦增加患者的心脏负荷,如对其行肝移植、外科门体分流术、经颈静脉肝内门体分流术等就有可能诱发心力衰竭,因此对其发生、发展以及演变过程的研究显得尤为必要。总结近年来肝硬化性心肌病的研究进展,旨在为临床肝硬化疾病的系统治疗提供帮助。 Cirrhotic cardiomyopathy is one of the complications of liver cirrhosis which can be characterized by diastolic dysfimction,high cardiac output and decreased systemic vascular resistance. Once cardiac load was increased,heart failure will be induced in the patients with cirrhotic cardiomyopathy, so it is necessary to study on its origins and development. This paper expects to provide an overview for clinical treatment of liver cirrhosis by concluding the progression of cirrhotic cardiomyopathy.
作者 高扬 李国杰
出处 《医学综述》 2008年第2期273-275,共3页 Medical Recapitulate
关键词 肝硬化性心肌病 彩色多普勒超声 定量分析技术 TEI指数 三维超声心动图 Cirrhotic cardiomyopathy Doppler echocardiography Qualification laboratory Tei index Three-dimensional echocardiography
  • 相关文献

参考文献5

二级参考文献201

  • 1Yi-Ling Ling~1 Ai-Hong Meng~1 Xiao-Yun Zhao~1 Bao-En Shan~2 Jun-Lan Zhang~1 Xiao-Peng Zhang~3 1 Department of Pathophysiology,Hebei Medical University,Shijiazhuang 050017,Hebei Province,China2 Research Center of Fourth Hospital,Hebei Medical University,Shijiazhuang 050000,Hebei Province,China3 Department of Chest Surgery of Hebei Provincial People’s Hospital,Shijiazhuang 050000,Hebei Province,China.Effect of cholecystokinin on cytokines during endotoxic shock in rats[J].World Journal of Gastroenterology,2001,7(5):667-671. 被引量:31
  • 2凌亦凌,黄善生,王乐丰,张君岚,万梅,郝荣利.八肽胆囊收缩素抗内毒素休克的实验研究[J].生理学报,1996,48(4):390-394. 被引量:56
  • 3[1]Lee SS. West J Med, 1989; 151(5): 530~535
  • 4[2]Ma ZH et al. Hepatology,1996; 24(2): 451~459
  • 5[3]Myers RP et al. Liver Transpl, 2000; 6(Suppl 1): S44~S52
  • 6[4]Azoulay D et al. Gastroenterology, 1993; 104(4): A873
  • 7[5]Wong F et al. Gut, 2001; 49(2): 268~275
  • 8[6]Liu H et al. J Gastroenterol Hepatol, 1999; 14(6): 600~608
  • 9[7]Kelbaek H et al. Am J Cardiol, 1984; 54(3): 854~855
  • 10[8]Grose RD et al. J Hepatol, 1997; 26(3): 326~332

共引文献61

同被引文献36

  • 1朱宏斌.肝硬化患者心功能改变的临床研究[J].临床医学,2005,25(6):27-29. 被引量:5
  • 2胡望明,孙晓枫,何家春,马月玲,王黎.肝硬化患者心脏结构和功能的超声改变及其与肝功能的关系[J].临床消化病杂志,2005,17(6):286-288. 被引量:4
  • 3Jimenez W, Arroyo V. Origins of Cardiac Dysfunction in Cirrhosis[J]. Gut,2003,52(10) : 1392-1394.
  • 4Moiler S, H enriksen J H. Cirrhotic Cardiomyopathy:A Pathophysiological Review of Circulatory Dysfunction in Liver Disease[J]. Heart,2002,87(1) :9-15.
  • 5Lee S S. Cardiac Abnormalities in Liver Cirrhosis[J]. West J Med, 1989,151 (5) : 530-535.
  • 6Ma Z,Lee S S. Cirrhotic Cardiomyopathy:Getting to the Heart of the Matter[J]. Hepatology,1996,24(2) :451-459.
  • 7Baik S K, Fouad T R, Lee S S. Cirrhotic Cardiomyopathy[J]. Orphanet J Rare Dis, 2007,2 : 15.
  • 8Pateron D, Beyne P, Laperche T, et al. Elevated Circulating Cardiac Troponin Ⅰ in Patients with Cirrhosis[J]. Hepatology, 1999,29(3) :640-643.
  • 9Wong F, Girgrah N, Graba J, et al. The Cardiac Response to Exercise in Cirrhosis[J]. Gut, 2001,49(2) :268-275.
  • 10Maisel A, Mueller C, Adams K Jr, et al. State of the art: using natri- uretic peptide levels in clinical practice. Eur J Heart Fail,2008 , 10(9) :824-839.

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部